Comparison Guide
Commercialization Strategy vs. IP Management Software
They sound similar but solve different jobs. One decides what to commercialize and how; the other administers the IP and deals once you have decided.
Last updated June 18, 2026.
In short
IP management software (such as Wellspring, Inteum, and IPfolio) is a system of record. It tracks invention disclosures, patent docketing, agreements, royalties, and compliance for the deals you have already decided to pursue.
Commercialization strategy software (such as Commercify) is a decision layer. It analyzes the market, recommends a commercialization pathway, sets market-validated pricing, and produces a go-to-market and launch plan — the work that decides which technologies to pursue and how.
The two are complementary, not competing. A strategy layer decides what to pursue; a system of record executes and administers it.
Side by side
| Dimension | IP management software | Commercialization strategy software |
|---|---|---|
| Core question it answers | How do we administer and protect this technology and its deals? | What should we commercialize, and how do we take it to market? |
| Primary job | System of record — disclosures, patent docketing, agreements, royalties, compliance. | Decision and strategy layer — market validation, pathway, pricing, launch plan. |
| Typical user | Licensing officers, IP managers, TTO administrators. | TTO leadership, researchers, and founders deciding what to pursue. |
| Main inputs | Invention disclosures, patent filings, contracts, financial data. | A technology or research result and its market context. |
| Main outputs | Dockets, agreements, royalty records, compliance reports. | A commercialization pathway, market-validated pricing, and a go-to-market plan. |
| Examples | Wellspring (Evolve), Inteum (Minuet), IPfolio. | Commercify. |
| Pricing | Not publicly available (quote-based). | Free GTM strategy generator; platform pricing on request. |
As of June 18, 2026. Verify current details with each vendor.
What IP management software does well
- Invention disclosure intake and patent docketing.
- Agreement, license, and royalty management.
- Bayh-Dole / iEdison and other compliance reporting.
- A durable system of record for the whole portfolio.
It is built to administer decisions, not to make them.
What a strategy layer adds
- Market validation for a technology or research result.
- Commercialization pathway recommendation (license, startup, partnership).
- Market-validated pricing.
- An actionable go-to-market and launch plan.
It decides what to pursue and how, before the system of record takes over.
Do you need both?
For most tech transfer offices, yes. The strategy layer is where you triage a backlog of disclosures, decide which have the strongest market opportunity, and define how to take them to market. The IP management system is where the resulting patents, agreements, and royalties are recorded and administered. They operate in sequence: decide, then execute.
If you only have a system of record, you can administer deals but still face the hardest question unaided: which technologies deserve the effort, and how to position them. If you only have strategy tooling, you can decide well but still need somewhere to docket and administer the outcomes.
Where Commercify fits
Disclosure: Commercify is the commercialization strategy layer described above. It is our product, and it does not replace your IP management system of record.
It turns a disclosure into a commercialization pathway, market-validated pricing, and a launch plan — the decisions your system of record then executes and administers.
Frequently asked questions
What is the difference between IP management software and commercialization strategy software?
IP management software (such as Wellspring Evolve, Inteum, or IPfolio) is a system of record: it tracks invention disclosures, patent docketing, agreements, royalties, and compliance for deals you have already decided to pursue. Commercialization strategy software (such as Commercify) is a decision layer: it analyzes the market, recommends a commercialization pathway, sets market-validated pricing, and produces a go-to-market and launch plan that informs which technologies to pursue in the first place. The two are complementary, not competing.
Does Commercify replace Wellspring or Inteum?
No. Wellspring and Inteum are IP management systems of record that run the operational lifecycle of a tech transfer office — docketing, agreements, royalties, and Bayh-Dole/iEdison compliance. Commercify does not docket patents or administer agreements; it generates the upstream commercialization strategy, pricing, and launch plan. Most offices use a strategy layer to decide what to pursue and a system of record to execute and administer it.
Which do I need first?
If you already run a portfolio of disclosures and licenses, you likely have or need IP management software as your system of record. A commercialization strategy layer adds the most value at the decision point — when you are triaging which disclosures to pursue and how to take them to market. Many tech transfer offices adopt strategy tooling to prioritize a backlog they are already tracking in an IP management system.
Can commercialization strategy software work alongside IP management systems?
Yes. The two solve different jobs, so they sit side by side: the strategy layer informs which opportunities to pursue and how to position them, and the IP management system records and administers the resulting patents, agreements, and royalties. Integrations to specialized systems (such as iEdison or patent docketing) are increasingly expected in this space.
Is IP management software enough on its own?
IP management software is essential for running a tech transfer office, but it is designed to administer decisions rather than make them. It does not tell you which technologies have the strongest market opportunity, what to charge, or how to take a technology to market. Those are the gaps a commercialization strategy layer fills.